4//SEC Filing
Glicklich Alan 4
Accession 0001209191-21-010386
CIK 0001435049other
Filed
Feb 11, 7:00 PM ET
Accepted
Feb 12, 6:11 PM ET
Size
8.2 KB
Accession
0001209191-21-010386
Insider Transaction Report
Form 4
Glicklich Alan
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2021-02-10+50,000→ 50,000 totalExercise: $15.14Exp: 2031-02-09→ Common Stock (50,000 underlying) - Award
Restricted Stock (RSU)(Common Stock)
2021-02-10+17,005→ 17,005 totalExp: 2024-02-10→ Common Stock (17,005 underlying)
Footnotes (3)
- [F1]The stock option vests as to 25% of the total shares on February 10, 2022, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
- [F2]Each RSU represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement.
- [F3]The RSUs vests as to one-third (1/3) of the total restricted stock units in equal annual installments beginning on February 10, 2022, until fully vested, subject to the reporting person's provision of service to the Issuer on each vesting date.
Documents
Issuer
CHINOOK THERAPEUTICS, INC.
CIK 0001435049
Entity typeother
Related Parties
1- filerCIK 0001823197
Filing Metadata
- Form type
- 4
- Filed
- Feb 11, 7:00 PM ET
- Accepted
- Feb 12, 6:11 PM ET
- Size
- 8.2 KB